Autism breakthrough as scientists find 44-cent pill that reverses symptoms

For years, families have been told that Autism Spectrum Disorder is too genetically complex for any single medication to make a meaningful difference.

With more than 800 genes involved, each contributing in different ways, the condition has long been seen as an intricate and difficult puzzle to solve.

Researchers at Yale University took a different approach, using zebrafish engineered with two key autism-related genes, SCN2A and DYRK1A.

They exposed these modified fish to 774 FDA-approved drugs, searching for any substance that could noticeably alter behavior.

One compound stood out: Levocarnitine, a treatment more commonly associated with rare metabolic disorders than autism care.

In the experiments, it seemed to improve how the fish processed and reacted to their environment, potentially by boosting activity in brain areas tied to communication, emotion, and social interaction.

However, researchers caution that this is not a cure, as only a subset of individuals share these specific genetic traits, and human trials are still essential—though the findings offer a hopeful new direction for future study.